• Home
  • Brochure
  • Scientific Committee
  • Speakers
  • Agenda
  • Venue
  • Contact
  • Submit Abstract
  • Register

SCIENTIFIC COMMITTEE

    view profile

    Matthew P. Janicki

    University of Illinois Chicago, USA
    view profile

    Illana Gozes

    Tel Aviv University, Israel
    view profile

    Paul Chazot

    Durham University, UK
    view profile

    Marie J. Hayes

    University of Maine, USA
    view profile

    José Julio Rodriguez Arellano

    IKERBASQUE, Spain
    view profile

    Leslie M Shaw

    University of Pennsylvania , USA

Matthew P. Janicki

University of Illinois Chicago

USA

Matthew P. Janicki, Ph.D. is co-President of the US National Task Group on Intellectual Disabilities and Dementia Practices and a research associate professor at the University of Illinois Chicago. An internationally recognized expert, he has served on the US federal Advisory Council on Alzheimer’s Research, Care, and Services and as a policy fellow with the US National Institute on Aging and the US Senate. He has led multiple nationally and internationally funded studies on aging and dementia in adults with intellectual disabilities, including work for the World Health Organization. He was founding editor of the Journal of Policy and Practice in Intellectual Disabilities and is widely published on dementia, aging, and disability policy.

Illana Gozes

Tel Aviv University

Israel

Professor Emerita Illana Gozes, formerly, The Lily and Avraham Gildor Chair for the Investigation of Growth Factors, currently, Head, Dr. Diana and Zelman Elton (Elbaum) Laboratory for Molecular Neuroendocrinology, Department of Human Molecular Genetics and Biochemistry, Faculty of Medical and Health Sciences, Adams Super Center for Brain Studies and Sagol School of Neuroscience, Tel Aviv University, President, European Society for Neurochemistry, Editor-in-Chief, Journal of Molecular Neuroscience, Vice President Drug Development ExoNavis Therapeutics Ltd. B.Sc., Tel Aviv University, Ph.D. Weizmann Institute of Science, Postdoctoral fellowships, MIT and Salk Institute (USA), Sabbaticals, NIH (Fogarty-Scholar-in-Residence) and Humboldt Research Award (Germany). Multiple prizes, papers and patents.

Paul Chazot

Durham University

UK

Professor Chazot’s research group focuses on the identification, characterisation and validation of novel drug targets for the treatment of the major chronic CNS pathologies. Professor Chazot has developed a range of new clinical development programmes over the last 20 years, one for chronic pain (Votucalis), one for post-concussion syndrome, and one for Alzheimer’s Disease (PBM-T 1068nm), the former at the pipeline stage, and the latter two at the Phase 2 clinical stage in the US, and soon to be UK. He is an academic partner for the spin-out company Nevrargenics, (http://nevrargenics.com). Ellorarxine has MHRA approval for ALS/FTD, recruiting in 2025. 

Marie J. Hayes

University of Maine

USA

Professor Marie Hayes, Ph.D., is active Emeritus professor from the University of Maine, the department of Psychology and the Program of Biomedical Science and Engineering. Dr. Hayes has worked as a biomedical scientist studying sleep deprivation in relation to microarousals, sleep movements and respiratory function in diseases of development and aging. Her collaborative research program on sleep and neurological disease has led to development of a novel sleep mattress for noninvasive recordings in aging individuals at risk for Alzheimer’s disease. Recent NIH work has focused on respiratory-movement coupling during sleep as a biobehavioral marker of early Alzheimer’s disease using machine learning to identify MCI risk in older adults from the community

José Julio Rodriguez Arellano

IKERBASQUE

Spain

Over 30 years of research experience in National Centers (Complutense University of Madrid & Institute Cajal –CSIC-) as well as International Centers in Switzerland (Novartis Pharma), France (INSERM), USA (Cornell Medical College
& Florida Atlantic University), United Kingdom (The open University & The University of Manchester and Czeck Republic (Institute of Experimental Medicine). Nowadays and from 2009, I work for IKERBASQUE (Basque
Foundation for Science, Spain.

Leslie M Shaw

University of Pennsylvania

USA

Leslie Shaw, PhD, directs the Biomarker Research Laboratory and the Toxicology Laboratory at the University of Pennsylvania Medical Center in the Department of Pathology and Laboratory Medicine at the University of Pennsylvania Medical Center.  He is co-director of the ADNI Biomarker Core laboratory and has published more than 350 scientific papers and reviews in the peer-reviewed literature.  Dr Shaw has extensive experience in the development, validation and implementation of biomarker methods in clinical investigations especially multicenter studies.  He leads the bioanalytical and clinical validation of Alzheimer’s disease biochemical biomarkers, using advanced mass spectrometric and immunoassay platforms, for the ADNI study where his focus is on the most relevant CSF and plasma biomarkers for early detection, differential diagnosis, monitoring disease progression, and treatment efficacy in Alzheimer’s disease.  He is especially interested in identifying and controlling factors that contribute to biomarker measurement variability.  Dr Shaw is working collaboratively with other investigators on statistical strategies for combining biochemical and imaging biomarkers for best detection of Alzheimer’s disease.  He is also conducting studies in clinical trials of the effects of new treatments on Alzheimer’s disease biomarkers.  Dr Shaw co-leads the Biomarker Core of the PENN ADRC.  Most recently, he has overseen the successful validation and use in measurements of the plasma AD biomarkers Aβ42/Aβ40, ptau217, GFAP and NfL in  ADNI participants and in participants of the PENN ADRC, both sponsored by the NIA.

Contact Information

+1-408-465-0048
[email protected]
+1-408-352-1010

Locate US

5201 Great America Pkwy #320,
Santa Clara, CA 95054,
United States "

Keep me Updated..!


Copyrights © 2020-21 Innovinc International, All Rights Reserved